Literature DB >> 32165718

Enduring effects of adolescent ketamine exposure on cocaine- and sucrose-induced reward in male and female C57BL/6 mice.

Israel Garcia-Carachure1, Francisco J Flores-Ramirez1, Samuel A Castillo1, Anapaula Themann1, Miguel A Arenivar1, Joshua Preciado-Piña1, Arturo R Zavala2, Mary Kay Lobo3, Sergio D Iñiguez4.   

Abstract

Ketamine has shown promising antidepressant efficacy for adolescent treatment-resistant depression. However, the potential enduring consequences of ketamine exposure have not been thoroughly evaluated. Thus, we examined if juvenile ketamine treatment results in long-lasting changes for the rewarding properties of sucrose and cocaine in adulthood, across three separate experiments. In Experiment 1, adolescent male and female C57BL/6 mice received ketamine (20 mg/kg) for 15 consecutive days (Postnatal Day [PD] 35-49). Twenty-one days later (PD70; adulthood) we examined their behavioral responsivity to sucrose (1%) on a two-bottle choice design, or cocaine (0, 5, 10 mg/kg) using the conditioned place preference (CPP) test. We found that juvenile ketamine-pretreatment increased preference for sucrose and environments paired with cocaine in male, but not female, adult mice. This long-term outcome was not observed when male and female mice received ketamine as adults (PD70-84) and tested for sucrose and cocaine preference 21-days later (Experiment 2). Similarly, in Experiment 3, no long-lasting differences in these measures were observed when adolescent male mice were exposed to concomitant ketamine and social stressors (PD35-44), namely the social defeat or vicarious defeat stress paradigms-procedures that mediated a depression-related phenotype (along with a ketamine antidepressant-like response). Collectively, we demonstrate that in the absence of physical or psychological stress, adolescent ketamine exposure increases later life preference for the rewarding properties of sucrose and cocaine in a sex- and age-specific manner. As such, this preclinical work provides awareness for the potential long-term behavioral consequences associated with juvenile ketamine exposure.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32165718      PMCID: PMC7360558          DOI: 10.1038/s41386-020-0654-7

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  71 in total

Review 1.  Antidepressant actions of ketamine: from molecular mechanisms to clinical practice.

Authors:  Lisa M Monteggia; Carlos Zarate
Journal:  Curr Opin Neurobiol       Date:  2015-01-03       Impact factor: 6.627

2.  Recent increases in depressive symptoms among US adolescents: trends from 1991 to 2018.

Authors:  Katherine M Keyes; Dahsan Gary; Patrick M O'Malley; Ava Hamilton; John Schulenberg
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-03-30       Impact factor: 4.328

3.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

4.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

5.  Anxiety and disruptive behavior mediate pathways from attention-deficit/hyperactivity disorder to depression.

Authors:  Arunima Roy; Albertine J Oldehinkel; Frank C Verhulst; Johan Ormel; Catharina A Hartman
Journal:  J Clin Psychiatry       Date:  2014-02       Impact factor: 4.384

6.  Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults.

Authors:  L Pezawas; H U Wittchen; H Pfister; J Angst; R Lieb; S Kasper
Journal:  Psychol Med       Date:  2003-04       Impact factor: 7.723

Review 7.  Childhood and adolescent depression: a review of the past 10 years. Part II.

Authors:  B Birmaher; N D Ryan; D E Williamson; D A Brent; J Kaufman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-12       Impact factor: 8.829

8.  Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study.

Authors:  Kathryn R Cullen; Palistha Amatya; Mark G Roback; Christina Sophia Albott; Melinda Westlund Schreiner; Yanan Ren; Lynn E Eberly; Patricia Carstedt; Ali Samikoglu; Meredith Gunlicks-Stoessel; Kristina Reigstad; Nathan Horek; Susannah Tye; Kelvin O Lim; Bonnie Klimes-Dougan
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-07-13       Impact factor: 2.576

9.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

10.  Network basis of suicidal ideation in depressed adolescents.

Authors:  Sarah J Ordaz; Meghan S Goyer; Tiffany C Ho; Manpreet K Singh; Ian H Gotlib
Journal:  J Affect Disord       Date:  2017-09-22       Impact factor: 4.839

View more
  6 in total

1.  Early-life ketamine exposure attenuates the preference for ethanol in adolescent Sprague-Dawley rats.

Authors:  Daniela Franco; Jennifer Zamudio; Kennedy M Blevins; Eric A Núñez-Larios; Ulises M Ricoy; Sergio D Iñiguez; Arturo R Zavala
Journal:  Behav Brain Res       Date:  2020-04-30       Impact factor: 3.332

2.  Repeated ketamine anesthesia during neurodevelopment upregulates hippocampal activity and enhances drug reward in male mice.

Authors:  Jianchen Cui; Xianshu Ju; Yulim Lee; Boohwi Hong; Hyojin Kang; Kihoon Han; Won-Ho Shin; Jiho Park; Min Joung Lee; Yoon Hee Kim; Youngkwon Ko; Jun Young Heo; Woosuk Chung
Journal:  Commun Biol       Date:  2022-07-15

Review 3.  Early Life Adversity and Neuropsychiatric Disease: Differential Outcomes and Translational Relevance of Rodent Models.

Authors:  Renée C Waters; Elizabeth Gould
Journal:  Front Syst Neurosci       Date:  2022-06-23

4.  Ketamine beyond anesthesia: Antidepressant effects and abuse potential.

Authors:  Keith A Trujillo; Sergio D Iñiguez
Journal:  Behav Brain Res       Date:  2020-07-31       Impact factor: 3.332

5.  Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice.

Authors:  Alessia Mastrodonato; Ina Pavlova; Noelle C Kee; Van Anh Pham; Josephine C McGowan; J John Mann; Christine A Denny
Journal:  Int J Neuropsychopharmacol       Date:  2022-06-21       Impact factor: 5.678

6.  Mice Cohabiting With Familiar Conspecific in Chronic Stress Condition Exhibit Methamphetamine-Induced Locomotor Sensitization and Augmented Consolation Behavior.

Authors:  Paulo Eduardo Carneiro de Oliveira; Isabela Miranda Carmona; Mariana Casarotto; Lara Maria Silveira; Anna Cecília Bezerra Oliveira; Azair Canto-de-Souza
Journal:  Front Behav Neurosci       Date:  2022-04-18       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.